Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 26 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 88.78 and Closed at: 88.78, which is -0.07% of previous session's close. It moved within a range of 87.47 and 89.61
The session was a Neutral session with an average volume of 390100, which is 60.52% of previous session's volumes.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 87.71 and resistance for tomorrow is 89.85
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 87.63, 86.48 resistance for tomorrow's hourly charts is 89.77, 90.76
10 Day SMA for Protagonist Therapeutics (PTGX) is 89.66 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 89.12 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 84.04 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 72.77 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 61.28 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 89.12 and 200 DMA is at 61.28, while 50 DMA and 100 DMA are at 84.04 and 72.77 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 89.12 and 20 EMA is at 88.36
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Fri Dec | 88.78 | 89.12 | 88.36 |
| 24 Wed Dec | 88.84 | 89.18 | 88.32 |
| 23 Tue Dec | 88.73 | 89.24 | 88.26 |
| 22 Mon Dec | 87.41 | 89.18 | 88.21 |
| 19 Fri Dec | 86.05 | 89.08 | 88.29 |
| 18 Thu Dec | 85.79 | 88.99 | 88.53 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 84.04 and 50 EMA is at 83.49
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Fri Dec | 88.78 | 84.04 | 83.49 |
| 24 Wed Dec | 88.84 | 83.82 | 83.27 |
| 23 Tue Dec | 88.73 | 83.58 | 83.04 |
| 22 Mon Dec | 87.41 | 83.39 | 82.81 |
| 19 Fri Dec | 86.05 | 83.38 | 82.62 |
| 18 Thu Dec | 85.79 | 83 | 82.48 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 72.77 and 100 EMA is at 75.47
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Fri Dec | 88.78 | 72.77 | 75.47 |
| 24 Wed Dec | 88.84 | 72.42 | 75.2 |
| 23 Tue Dec | 88.73 | 72.07 | 74.92 |
| 22 Mon Dec | 87.41 | 71.72 | 74.64 |
| 19 Fri Dec | 86.05 | 71.39 | 74.38 |
| 18 Thu Dec | 85.79 | 71.07 | 74.14 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 61.28 and 200 EMA is at 65.49
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Fri Dec | 88.78 | 61.28 | 65.49 |
| 24 Wed Dec | 88.84 | 61.12 | 65.25 |
| 23 Tue Dec | 88.73 | 60.97 | 65.01 |
| 22 Mon Dec | 87.41 | 60.81 | 64.77 |
| 19 Fri Dec | 86.05 | 60.56 | 64.54 |
| 18 Thu Dec | 85.79 | 60.33 | 64.32 |
Wave Life has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Wave Life, about 130.35% more returns!
Pulse Biosciences has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Pulse Biosciences, about 6.55% more returns!
Merus N has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Merus N, about 2.17% more returns!
Protagonist Therapeutics has performed better than Ascendis Pharma in short term. Holding Protagonist Therapeutics could be a better choice for now!
Atricure Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Atricure Inc, about 13.02% more returns!
Avadel Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Avadel Pharmaceuticals, about 1.83% more returns!
Benitec Biopharma has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Benitec Biopharma, about 2.44% more returns!
Cidara Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Cidara Therapeutics, about 1.78% more returns!
Champions Oncology has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Champions Oncology, about 8.09% more returns!
Eyegate Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 0.78% more returns!
Fennec Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 0.14% more returns!
Protagonist Therapeutics has performed better than Genprex Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Harrow Health has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Harrow Health, about 21.25% more returns!
Protagonist Therapeutics has performed better than Ironwood Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Kalvista Pharmaceuticals has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 6.2% more returns!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term but the sell signal is initial and weak.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Protagonist Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Protagonist Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 89.29 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
